{"nct_id":"NCT02435433","title":"A Study of Ramucirumab (LY3009806) Versus Placebo in Participants With Hepatocellular Carcinoma and Elevated Baseline Alpha-Fetoprotein","status":"COMPLETED","status_verified_date":"2022-12-01","start_date":"2015-07-20","start_date_type":"ACTUAL","primary_completion_date":"2018-03-15","primary_completion_date_type":"ACTUAL","completion_date":"2021-11-19","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["LLY"]}